Eukaryotic Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kruppa, M.
Right arrow Articles by Calderone, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kruppa, M.
Right arrow Articles by Calderone, R. A.

 Previous Article

Eukaryotic Cell, August 2004, p. 1062-1065, Vol. 3, No. 4
1535-9778/04/$08.00+0     DOI: 10.1128/EC.3.4.1062-1065.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

The Two-Component Signal Transduction Protein Chk1p Regulates Quorum Sensing in Candida albicans

Michael Kruppa,{dagger} Bastiaan P. Krom,{dagger} Neeraj Chauhan, Adrienne V. Bambach, Ronald L. Cihlar, and Richard A. Calderone*

Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, D.C. 20057

Received 15 April 2004/ Accepted 27 April 2004


   ABSTRACT
Top
 Abstract
Text
 References
 
Regulation of hyphal morphogenesis in Candida albicans can occur through quorum sensing (QS). A QS signal, farnesol, is produced during high-density growth and inhibits morphogenesis. However, the signal transduction pathway that regulates QS is unknown. Here, we show that a C. albicans mutant lacking Chk1p but not either the Sln1p or the Nik1p histidine kinase is refractory to the inhibitory effect of farnesol both in cell suspension and during the formation of a biofilm. This study is the first to demonstrate a role for a two-component signal transduction protein in QS by a eukaryotic organism.


   TEXT
Top
 Abstract
 Text
References
 
Cell density is a critical factor in the regulation of Candida albicans hyphal morphogenesis. At a density of >106 cells/ml, yeast cells do not shift (germinate) to hyphae or do so at low frequencies, while at a density of <106 cells/ml, germination occurs (3). The relationship between cell density and new gene transcription (hyphal morphogenesis) resembles quorum sensing (QS) in some bacteria (14). Recent observations indicate that a QS system operates in C. albicans and that the isoprenoid farnesol is the QS autoinducer signal (12). Cells exposed to farnesol do not germinate, even at low cell densities. However, the regulatory and signal transduction events that direct QS are unknown, not only for C. albicans but for other fungi and eukaryotes in general. In some bacteria, two-component signaling regulates QS. Since C. albicans has several two-component signal proteins that are critical to a number of processes, including cell wall biosynthesis, adaptation to stress conditions, and virulence, our rationale was that farnesol sensing could be mediated through two-component proteins. C. albicans has three hybrid-histidine kinases, two of which have orthologues in Saccharomyces cerevisiae (Sln1p) and Neurospora crassa (Nik1p) that are presumed to play a role in an osmotic stress response (1, 15, 19, 20). The third histidine kinase, Chk1p, has some similarity to two Schizosaccharomyces pombe proteins, Mak2p and Mak3p, which are known to function as sensors for oxidative stress (2, 5). In addition to the histidine kinases, C. albicans has two response regulator proteins, Ssk1p and Skn7p, whose S. cerevisiae homologs act downstream of the Sln1p histidine kinase (11). In C. albicans, Ssk1p and Skn7p function in the adaptation of cells to oxidant stress, while Ssk1p, in addition, regulates the expression of structural cell wall proteins and negatively regulates Chk1p expression (7, 18).

The C. albicans strains used for this study have been described previously (4, 6, 9, 20). Unless noted, cells were routinely cultured in YPD (1% yeast extract, 2% dextrose, 2% peptone) or YNB (0.67% yeast nitrogen base [pH 7.0], 50 mM glucose) at 30°C. To assess whether the two-component signal transduction proteins of C. albicans play a role in QS, all strains (see Table 1) were first cultured overnight at 30°C in YPD. Subsequently, the cells were washed twice and then inoculated into 10 ml of prewarmed medium 199 (pH 7.5) with or without 250 µM trans,trans-farnesol (Sigma-Aldrich, St. Louis, Mo.) at a concentration of 5 x 105 cells/ml. Cells were incubated at 37°C for 4 h, in order to allow germination to occur. Identical experiments were performed with 10% serum at 37°C as the inducing condition. The percentages of yeast cells and hyphae were then determined by light microscopy. Photographs were taken using a Canon digital camera, and figures were prepared with Adobe Photoshop 6.0. The C. albicans sln1, nik1, and chk1 histidine kinase mutants and the ssk1 response regulator mutant were compared to strain CAF2-1 (wild type) in hypha-inducing medium (10% serum or medium 199 [pH 7.5] with or without 250 µM farnesol). In medium 199 (pH 7.5) lacking farnesol, germination proceeded normally (89 to 96%) for all strains (Fig. 1, left column; Table 1). In the presence of farnesol, the percentages of germination for CAF2-1 and for strains S (sln1/sln1), N (nik1/nik1), and SSK21 (ssk1/ssk1) decreased significantly to values ranging from 15 to 30%, while germination of the chk1 mutant (CHK21) was 84% of that of CAF2-1 (Fig. 1, right column; Table 1). The germination of a strain reconstituted with a single copy of CHK1 (CHK23) was intermediate to that of CAF2-1 and the null counterpart (Fig. 1, right column, panel for CHK23; Table 1), indicating that the phenotype observed may be a result of the gene dosage. Similar results were seen when strains were grown in 10% serum (data not shown), indicating that the farnesol response is not medium dependent.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Germination of C. albicans in the presence or absence of 250 µM farnesola

 


View larger version (54K):
[in this window]
[in a new window]
  		FIG. 1. Representative photomicrographs of C. albicans grown without (left) and with (right) 250 µM farnesol. Strains were grown for 4 h at 37°C in medium 199 (pH 7.5) at a density of 5 x 105 cells/ml.

 
An important aspect of the effect of farnesol on C. albicans is its influence on biofilm formation (8, 16). C. albicans forms biofilms on a variety of substrates both in vitro and in clinical settings, such as indwelling intravenous catheters of patients (8). In the clinical setting, biofilm formation also represents a problem for therapeutic management of patients due to the resistance of the biofilm cells to antifungal therapy. In vitro studies indicate that farnesol inhibits biofilm formation, possibly by inhibiting the ability of the organism to shift to a filamentous morphology (16). Since our data indicate that the chk1 null mutant is not morphologically responsive to farnesol compared to parental and other mutants, the effect of farnesol on biofilm formation by this mutant was determined. C. albicans strains were grown overnight in YNB (pH 7) containing 50 mM glucose at 30°C, harvested, and washed twice in phosphate-buffered saline (PBS). The cell density was standardized to 107 CFU/ml, and cells (100 µl of cell suspension) were allowed to adhere to the bottoms of 96-well microtiter plates. After 90 min of incubation at 37°C, the nonadhered cells were removed by washing twice with 200 µl of PBS. Then, 200 µl of YNB (pH 7) containing 50 mM glucose with or without farnesol (25 or 250 µM) was added, and biofilms were allowed to develop for 48 h at 37°C while being shaken at 150 rpm. The biofilms were washed twice with 200 µl of PBS and incubated in a solution containing 150 µl of PBS with 50 mM glucose, 2.5 mg of XTT [2,3-bis(2-methoxy-4-nitro-sulfophenyl)-5-[(phenylamine)carbonyl]-2H-tetrazolium hydroxide]/ml, and 2 µM menadione (Sigma-Aldrich) (16). After 2 h of incubation at 37°C, 100 µl of each sample was transferred to a fresh plate, and the reduction in XTT was determined by measuring the optical density of the sample at 492 nm. In the absence of farnesol, biofilm formation occurred for all strains (Fig. 2). However, in the presence of subinhibitory concentrations of farnesol (25 µM), CAF2-1 biofilm formation was reduced by 60%, while strain CHK21 (chk1/chk1) formed a biofilm that was approximately twofold greater than that of CAF2-1 (Fig. 2). At a 250 µM concentration of farnesol, CAF2-1 again produced a biofilm that was approximately 40% of the size of that produced in the absence of farnesol by that strain. In contrast, the biofilm formation of the chk1 mutant exceeded that of CAF2-1. At a 25 µM concentration of farnesol, strain CHK23, containing one copy of CHK1, formed a biofilm somewhat intermediate in size to those formed by strain CAF2-1 and the CHK21 null mutant (averaging 55% of the sizes of those formed by CAF2-1 and CHK21) (Fig. 2). With 250 µM farnesol, biofilm formation by CHK23 was equal to that of CAF2-1. The ssk1, sln1, and nik1 null mutants resembled CAF2-1 and formed biofilms only in the absence of farnesol (data not shown). The data on biofilm formation by these strains support the observed effects of farnesol on germination (Fig. 1; Table 1).



View larger version (44K):
[in this window]
[in a new window]
  		FIG. 2. Influence of farnesol on biofilm formation. CHK21 (chk1/chk1{Delta}) is nonresponsive to farnesol. Biofilm formation was assessed using the XTT metabolic assay. The percentages of CHK21 and CHK23 cells that formed a biofilm are indicated relative to that of CAF2-1 without farnesol (black bars), with 25 µM farnesol (white bars), and with 250 µM farnesol (grey bars). The data represent averages of the results from four experiments.

 
Our observation of the role of the two-component signal transduction protein Chk1p in QS is the first for a eukaryotic organism. However, it is unclear how new gene transcription is initiated upon perception of the farnesol signal. Since Chk1p is a cytoplasmic protein, it is possible that another protein, which is upstream of Chk1p, perceives the farnesol signal and then activates a pathway that includes Chk1p. This hypothesis may be quite likely since no apparent motifs are found in Chk1p that would suggest a binding site for farnesol. The histidine box domain and the receiver domain of Chk1p contain residues of histidine and aspartate, respectively, that may be sequentially phosphorylated during signal transfer. In addition, a partial mitogen-activated protein kinase domain that may also be critical to signal transfer is located in the N-terminal half of Chk1p (5). The phenotype of the chk1 mutant in the presence of farnesol suggests that this kinase participates in a signal pathway. If so, this pathway would be unique among organisms that utilize two-component signal transduction.

Our observation that QS is mediated through a two-component pathway may help in developing new strategies to inhibit hyphal morphogenic shifting in yeast cells. Furthermore, QS inhibitors in bacteria have been shown to be successful as antibiotics against biofilm formation (10). Since two-component signaling genes are not found in humans, it is likely that the development of two-component inhibitors may be useful in the treatment of candidiasis and candidal biofilms as well as in the dissection of the QS pathway. Such studies have recently been reported (13, 17).


   ACKNOWLEDGMENTS
 
This work was supported in part by Public Health Service grants NIAID-47047 and NIAID-43465 to R.A.C. and CA88456 and DE13478 to R.L.C. M.K. was supported in part by NIH training grant T32AI37251. B.P.K. was supported in part by a grant from The Netherlands Organization for Scientific Research (NWO).

B.P.K. thanks Jesse Cohen for his technical assistance and Julia Douglas and her laboratory personnel for their valuable discussions. M.K. thanks Katie Kierpiec for assistance with the morphogenesis assays of strains grown in medium 199. Strains S and N (sln and nik mutants) were kindly provided by Mikio Arisawa, Nippon Roche, Kamakura, Japan.


   FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, DC 20057. Phone: (202) 687-1137. Fax: (202) 687-1800. E-mail: calderor{at}georgetown.edu. Back

{dagger} M.K. and B.P.K. contributed equally to this work. Back


   REFERENCES
Top
 Abstract
 Text
 References
 

  1. Alex, L. A., C. Korch, C. P. Selitrennikoff, and M. I. Simon. 1998. COS1, a two-component histidine kinase that is involved in hyphal development in the opportunistic pathogen Candida albicans. Proc. Natl. Acad. Sci. USA 95:7069-7073.[Abstract/Free Full Text]
  2. Buck, V., J. Quinn, T. Soto Pino, H. Martin, J. Saldanha, K. Makino, B. A. Morgan, and J. B. Millar. 2001. Peroxide sensors for the fission yeast stress-activated mitogen-activated protein kinase pathway. Mol. Biol. Cell 12:407-419.[Abstract/Free Full Text]
  3. Calderone, R. A. 2002. Candida and candidiasis. ASM Press, Washington, D.C.
  4. Calera, J. A., and R. Calderone. 1999. Flocculation of hyphae is associated with a deletion in the putative CaHK1 two-component histidine kinase gene from Candida albicans. Microbiology 145:1431-1442.[Abstract]
  5. Calera, J. A., G. H. Choi, and R. A. Calderone. 1998. Identification of a putative histidine kinase two-component phosphorelay gene (CaHK1) in Candida albicans. Yeast 14:665-674.[CrossRef][Medline]
  6. Calera, J. A., X.-J. Zhao, and R. Calderone. 2000. Defective hyphal development and avirulence caused by a deletion of the SSK1 response regulator gene in Candida albicans. Infect. Immun. 68:518-525.[Abstract/Free Full Text]
  7. Chauhan, N., D. Inglis, E. Roman, J. Pla, D. Li, J. A. Calera, and R. Calderone. 2003. Candida albicans response regulator gene SSK1 regulates a subset of genes whose functions are associated with cell wall biosynthesis and adaptation to oxidative stress. Eukaryot. Cell 2:1018-1024.[Abstract/Free Full Text]
  8. Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.[CrossRef][Medline]
  9. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.[Abstract]
  10. Hentzer, M., and M. Givskov. 2003. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J. Clin. Investig. 112:1300-1307.[CrossRef][Medline]
  11. Hohmann, S. 2002. Osmotic stress signaling and osmoadaptation in yeasts. Microbiol. Mol. Biol. Rev. 66:300-372.[Abstract/Free Full Text]
  12. Hornby, J. M., E. C. Jensen, A. D. Lisec, J. J. Tasto, B. Jahnke, R. Shoemaker, P. Dussault, and K. W. Nickerson. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992.[Abstract/Free Full Text]
  13. Kim, S., E. Kim, D. S. Shin, H. Kang, and K. B. Oh. 2002. Evaluation of morphogenic regulatory activity of farnesoic acid and its derivatives against Candida albicans dimorphism. Bioorg. Med. Chem. Lett. 12:895-898.[CrossRef][Medline]
  14. Miller, M. B., and B. L. Bassler. 2001. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55:165-199.[CrossRef][Medline]
  15. Nagahashi, S., T. Mio, N. Ono, T. Yamada-Okabe, M. Arisawa, H. Bussey, and H. Yamada-Okabe. 1998. Isolation of CaSLN1 and CaNIK1, the genes for osmosensing histidine kinase homologues, from the pathogenic fungus Candida albicans. Microbiology 144:425-432.[Abstract]
  16. Ramage, G., S. P. Saville, B. L. Wickes, and J. L. López-Ribot. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463.[Abstract/Free Full Text]
  17. Shchepin, R., J. M. Hornby, E. Burger, T. Niessen, P. Dussault, and K. W. Nickerson. 2003. Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogs. Chem. Biol. 10:743-750.[CrossRef][Medline]
  18. Singh, P., N. Chauhan, A. Ghosh, F. Dixon, and R. Calderone. 2004. SKN7 of Candida albicans: mutant construction and phenotype analysis. Infect. Immun. 72:2390-2394.[Abstract/Free Full Text]
  19. Srikantha, T., L. Tsai, K. Daniels, L. Enger, K. Highley, and D. R. Soll. 1998. The two-component hybrid kinase regulator CaNIK1 of Candida albicans. Microbiology 144:2715-2729.[Abstract]
  20. Yamada-Okabe, T., T. Mio, N. Ono, Y. Kashima, M. Matsui, M. Arisawa, and H. Yamada-Okabe. 1999. Roles of three histidine kinase genes in hyphal development and virulence of the pathogenic fungus Candida albicans. J. Bacteriol. 181:7243-7247.[Abstract/Free Full Text]

Eukaryotic Cell, August 2004, p. 1062-1065, Vol. 3, No. 4
1535-9778/04/$08.00+0     DOI: 10.1128/EC.3.4.1062-1065.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kruppa, M.
Right arrow Articles by Calderone, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kruppa, M.
Right arrow Articles by Calderone, R. A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Appl. Environ. Microbiol. Infect. Immun. J. Bacteriol.
Mol. Cell Biol. Microbiol. Mol. Biol. Rev. ALL ASM JOURNALS